Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Nov 28, 2017 at 10:15 AM EST

Apollo Endosurgery Surges on FDA Approval

Shares of Apollo Endosurgery saw a healthy gain early on Tuesday after the company announced it had received 510k clearance…

Chris Lange | Nov 27, 2017 at 11:55 AM EST

Will Teva’s Restructuring Stop the Bleeding?

Shares of Teva Pharmaceutical Industries rose Monday after the company announced a reorganization some of its top leadership positions.

Chris Lange | Nov 27, 2017 at 11:10 AM EST

Odonate Therapeutics Gears Up for IPO

Odonate Therapeutics expects to price more than 5 million shares in a range that results in an initial public offering…

Paul Ausick | Nov 27, 2017 at 11:00 AM EST

NVIDIA, GE Healthcare Strike Deal on AI

General Electric's Healthcare segment signed a deal Sunday with Nvidia to use the chipmaker's artificial intelligence platform. GE Healthcare also…

Chris Lange | Nov 27, 2017 at 10:05 AM EST

Alkermes Could Win Big With New Biogen Partnership

Alkermes saw its shares make a handy gain to start off the week, after the firm announced that it has…

Chris Lange | Nov 27, 2017 at 9:45 AM EST

Denali Therapeutics Announces Potential Pricing for IPO

Neurodegenerative disease focused Denali Therapeutics intends to price more than 8 million shares in a range that results in an…

Chris Lange | Nov 21, 2017 at 12:40 PM EST

Why Celsion Could Still More Than Double on Top of Good News

Celsion Corp. (NASDAQ: CLSN) watched its shares make an incredible gain on Tuesday after it received an even bigger upgrade…

Chris Lange | Nov 21, 2017 at 11:04 AM EST

Cytokinetics Crumbles on Late-Stage Results

Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesday’s session after the firm reported negative…

Chris Lange | Nov 20, 2017 at 1:32 PM EST

Summit Therapeutics Closes in on DMD Results

Summit Therapeutics PLC (NASDAQ: SMMT) saw its shares make a handy gain on Monday after the firm announced that it…

Chris Lange | Nov 16, 2017 at 10:35 AM EST

Achillion Pharmaceuticals Gears Up for Secondary Offering

Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.

Chris Lange | Nov 15, 2017 at 8:45 AM EST

Acorda Therapeutics Gets Crushed After Halting Parkinson’s Trial

Acorda Therapeutics saw its shares drop sharply following an announcement that it had paused new enrollment in a long-term safety…

Chris Lange | Nov 14, 2017 at 1:25 PM EST

Loxo Loses Out Despite Signing Big Cancer Deal

Loxo Oncology has announced that it will be partnering with Bayer to develop and commercialize larotrectinib and LOXO-195. Investors seem…

Chris Lange | Nov 13, 2017 at 1:30 PM EST

Why Argus Is Taking a Step Back on Gilead Sciences

Gilead Sciences, Inc. (NASDAQ: GILD) saw its shares take a step back on Monday after an independent research firm downgraded…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Trey Thoelcke | Nov 10, 2017 at 11:15 AM EST

3 Companies Spearheading the Antibiotics Space in 2018

Thanks to progress made in 2017 though, it looks like 2018 could see both a radically new way of delivering…

1 … 149 150 151 152 153 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Apollo Endosurgery Surges on FDA Approval

Will Teva’s Restructuring Stop the Bleeding?

Odonate Therapeutics Gears Up for IPO

NVIDIA, GE Healthcare Strike Deal on AI

Alkermes Could Win Big With New Biogen Partnership

Denali Therapeutics Announces Potential Pricing for IPO

Why Celsion Could Still More Than Double on Top of Good News

Cytokinetics Crumbles on Late-Stage Results

Summit Therapeutics Closes in on DMD Results

Achillion Pharmaceuticals Gears Up for Secondary Offering

Acorda Therapeutics Gets Crushed After Halting Parkinson’s Trial

Loxo Loses Out Despite Signing Big Cancer Deal

Why Argus Is Taking a Step Back on Gilead Sciences

Short Sellers Back Way Off Major Pharma

3 Companies Spearheading the Antibiotics Space in 2018

Bitcoin Price: BTC Just Reclaimed the Bull Market Support Band for the First Time in 6 Months

ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Bitcoin Price: BTC Just Reclaimed the Bull Market Support Band for the First Time in 6 Months

ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40

Health and Healthcare Articles

All Health and Healthcare Articles

Apollo Endosurgery Surges on FDA Approval

Will Teva’s Restructuring Stop the Bleeding?

Odonate Therapeutics Gears Up for IPO

NVIDIA, GE Healthcare Strike Deal on AI

Alkermes Could Win Big With New Biogen Partnership

Denali Therapeutics Announces Potential Pricing for IPO

Why Celsion Could Still More Than Double on Top of Good News

Cytokinetics Crumbles on Late-Stage Results

Summit Therapeutics Closes in on DMD Results

Achillion Pharmaceuticals Gears Up for Secondary Offering

Acorda Therapeutics Gets Crushed After Halting Parkinson’s Trial

Loxo Loses Out Despite Signing Big Cancer Deal

Why Argus Is Taking a Step Back on Gilead Sciences

Short Sellers Back Way Off Major Pharma

3 Companies Spearheading the Antibiotics Space in 2018

Bitcoin Price: BTC Just Reclaimed the Bull Market Support Band for the First Time in 6 Months

ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how